Rising profits for AstraZeneca
The Local Sweden - [email protected]
Published: 27 Oct, 2005 CET.
Updated: Thu 27 Oct 2005 13:45 CET
Anglo-Swedish drugs giant AstraZeneca announced on Thursday that the company's pre-tax profit stood at $1.743 billion during the third quarter of 2005, up 23 percent from the equivalent figure last year and better than analysts' forecasts.
The pre-tax figure compared with $1.419 billion in the third quarter of 2004. Group sales meanwhile jumped by 10 percent $5.789 billion during the three months to the end of September.
Analysts' consensus forecasts had been for pre-tax profit of $1.73 billion and sales of 5.7 billion.
Comments
See Also
The pre-tax figure compared with $1.419 billion in the third quarter of 2004. Group sales meanwhile jumped by 10 percent $5.789 billion during the three months to the end of September.
Analysts' consensus forecasts had been for pre-tax profit of $1.73 billion and sales of 5.7 billion.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.